Dynavax Technologies Corporation (DVAX) Financial Statements (2025 and earlier)

Company Profile

Business Address 2100 POWELL STREET
EMERYVILLE, CA 94608
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:742,302624,395546,000165,000151,100145,500
Cash and cash equivalents150,279202,004436,18932,07339,88449,348
Short-term investments592,023422,391109,761132,963111,17196,188
Other undisclosed cash, cash equivalents, and short-term investments   50(36)45(36)
Receivables(12,313)     
Inventory, net of allowances, customer advances and progress billings53,29059,44661,33563,68941,33219,022
Inventory53,29059,44661,33563,68941,33219,022
Other undisclosed current assets75,841233,144365,18561,32616,2219,842
Total current assets:859,120916,985972,520290,015208,653174,364
Noncurrent Assets
Operating lease, right-of-use asset24,28725,74525,96426,58330,252
Property, plant and equipment37,29737,59635,02030,56732,02217,064
Intangible assets, net (including goodwill)2,0672,0062,1252,2974,58113,861
Goodwill2,0672,0062,1252,2972,0812,144
Intangible assets, net (excluding goodwill)     2,50011,717
Restricted cash and investments  207219237216619
Other noncurrent assets74,3253,3113,3983,5733,3444,976
Total noncurrent assets:137,97668,86566,72663,25770,41536,520
TOTAL ASSETS:997,096985,8501,039,246353,272279,068210,884
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities54,69333,93065,40731,09530,73329,377
Employee-related liabilities13,0118,6846,6538,058
Accounts payable5,2453,2112,6003,3129,2785,278
Accrued liabilities49,44830,71949,79619,09914,80216,041
Deferred revenue   55,400  
Debt     3,039 
Restructuring reserve     675 
Other liabilities4,5203,6312,5903,2479,9877,000
Other undisclosed current liabilities2,982112,513433,00543,0698,6131,656
Total current liabilities:62,195150,074556,40277,41153,04738,033
Noncurrent Liabilities
Long-term debt and lease obligation   34,316214,600216,446100,871
Long-term debt, excluding current maturities    179,811178,601100,871
Liabilities, other than long-term debt29,79433,1855,6642,5681,2858,915
Other liabilities743845,6642,5681,2858,915
Operating lease, liability29,72032,80134,31634,78937,845
Other undisclosed noncurrent liabilities283,035221,578220,490   
Total noncurrent liabilities:312,829254,763260,470217,168217,731109,786
Total liabilities:375,024404,837816,872294,579270,778147,819
Equity
Equity, attributable to parent622,072581,013222,37458,6938,29063,065
Common stock1301281231108463
Additional paid in capital1,554,6341,510,5181,441,8681,352,3741,229,4171,131,241
Accumulated other comprehensive income (loss)(2,108)(5,438)(2,266)273(2,387)(2,015)
Accumulated deficit(930,584)(924,195)(1,217,351)(1,294,064)(1,218,824)(1,066,224)
Total equity:622,072581,013222,37458,6938,29063,065
TOTAL LIABILITIES AND EQUITY:997,096985,8501,039,246353,272279,068210,884

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues232,284722,683439,44246,55135,2198,198
Sublease income7,577  7,7062,619
Cost of revenue(57,138)(262,153)(173,572)(2,786)(10,433)(10,862)
Cost of goods and services sold(50,167)(262,153)(173,572)(2,500)(9,217)(10,862)
Gross profit:175,146460,530265,87043,76524,786(2,664)
Operating expenses(212,174)(178,008)(132,384)(112,136)(159,629)(161,517)
Other undisclosed operating income  1,0001,000  10,862
Operating income (loss):(37,028)283,522134,486(68,371)(134,843)(153,319)
Nonoperating income31,8418,0231,0623634,1013,758
Investment income, nonoperating31,9937,9121401,2603,3703,828
Other nonoperating income (expense)(152)111922(897)731(70)
Interest and debt expense(6,757)(6,732)(16,408)(19,062)(16,977)(9,338)
Other undisclosed loss from continuing operations before equity method investments, income taxes     (4,881) 
Income (loss) from continuing operations before equity method investments, income taxes:(11,944)284,813119,140(87,070)(152,600)(158,899)
Other undisclosed income (loss) from continuing operations before income taxes7,5779,486(41,619)   
Income (loss) from continuing operations before income taxes:(4,367)294,29977,521(87,070)(152,600)(158,899)
Income tax expense(2,022)(1,143)(808)   
Income (loss) from continuing operations:(6,389)293,15676,713(87,070)(152,600)(158,899)
Income (loss) before gain (loss) on sale of properties:76,713(87,070)(152,600)(158,899)
Net income (loss):(6,389)293,15676,713(87,070)(152,600)(158,899)
Other undisclosed net income attributable to parent    11,830  
Net income (loss) attributable to parent:(6,389)293,15676,713(75,240)(152,600)(158,899)
Preferred stock dividends and other adjustments     (3,267) 
Undistributed earnings (loss) allocated to participating securities, basic  2834,569   
Other undisclosed net loss available to common stockholders, basic  (566)(9,138)   
Net income (loss) available to common stockholders, basic:(6,389)292,87372,144(75,240)(155,867)(158,899)
Other undisclosed net income (loss) available to common stockholders, diluted 3,5263,547(4,124)  
Net income (loss) available to common stockholders, diluted:(6,389)296,39975,691(79,364)(155,867)(158,899)

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):(6,389)293,15676,713(87,070)(152,600)(158,899)
Other comprehensive income (loss)3,330(3,172)(2,539)2,660(372)(1,134)
Comprehensive income (loss):(3,059)289,98474,174(84,410)(152,972)(160,033)
Other undisclosed comprehensive income, net of tax, attributable to parent    11,830  
Comprehensive income (loss), net of tax, attributable to parent:(3,059)289,98474,174(72,580)(152,972)(160,033)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: